ANVS
:Annovis Bio Inc
Snapshot
|
Charting
|
News
|
Options
$8.31
3.49%
$0.28
NYSE
7:02p ET
May 16 '24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, ...
BusinessWire
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Latest Story
Top Stories on ANVS
No News Available
The Law Offices of Frank R. Cruz Announces Investigation of Annovis B...
3:09p ET May 16 '24
BusinessWire
Annovis Bio Provides Corporate Updates and Announces First Quarter 20...
7:30a ET May 13 '24
GlobeNewswire
Annovis Announces Unblinding of the Buntanetap Phase III Data in Park...
7:30a ET May 9 '24
GlobeNewswire
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
7:30a ET May 6 '24
GlobeNewswire
Annovis Bio Announces Statistically Significant Phase II/III Data in ...
10:10a ET April 29 '24
GlobeNewswire
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and...
7:30a ET April 2 '24
GlobeNewswire
Annovis Announces Publication That Supports Understanding of Buntanet...
8:00a ET April 1 '24
GlobeNewswire
Annovis Bio Provides Data Announcement Update for the Phase II/III St...
7:30a ET March 20 '24
GlobeNewswire
Annovis Bio Announces Participation in Forum Discussion at AD/PD(TM) ...
8:00a ET February 27 '24
GlobeNewswire
Market data provided by
News provided by